KIF11 and glioblastoma: Indeed, Liu and co-workers demonstrated that Eg5 promotes the expression of GSC markers, such as KLF4, OCT4, or NANOG, and the expression of the CD133 stemness marker, thus promoting the stemness associated with chemoresistance in TP53 mutant GBM.